Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

STEMETIL DIN 01927779

Status: Cancelled Post Market
Holder: SANOFI-AVENTIS CANADA INC
Molecule: PROCHLORPERAZINE (PROCHLORPERAZINE MESYLATE)

Health Canada record

Active ingredient(s)PROCHLORPERAZINE (PROCHLORPERAZINE MESYLATE) 5 MG
Dosage formSolution
RouteIntramuscular; Intravenous
SchedulePRESCRIPTION
ClassHuman
ATCN05AB04 PROCHLORPERAZINE
Original market date31-Dec-1957
Current status date30-Jan-2007
SourceHealth Canada DPD

Establishment licence of the holder

sanofi-aventis Canada Inc. — licence 101470, currently licensed, last inspection rating C (2026-02-17).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing PROCHLORPERAZINE (PROCHLORPERAZINE MESYLATE)

DINProductCompanyFormStrengthStatus
00753645PMS PROCHLORPERAZINE INJ 5MG/MLPHARMASCIENCE INCSolutionPROCHLORPERAZINE (PROCHLORPERAZINE MESYLATE) 5 MGCancelled Post Market
00789747PROCHLORPERAZINE MESYLATE INJ 5MG/MLSANDOZ CANADA INCORPORATEDLiquidPROCHLORPERAZINE (PROCHLORPERAZINE MESYLATE) 5 MGCancelled Post Market
01927787STEMETIL LIQ 5MG/5MLAVENTIS PHARMA INCSyrupPROCHLORPERAZINE (PROCHLORPERAZINE MESYLATE) 5 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
79882006-05-30New Drug Submission (NDS)MANUFACTURER NAME CHANGE
13772000-11-14New Drug Submission (NDS)
Request a quote for STEMETIL

How to read a Canadian DIN record